This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
GeoVax advances GEO-MVA, an MVA-based mpox/smallpox vaccine, as global disease threats escalate. Phase 3 trial launching Q4 2026 with EMA support. Strengthening domestic biodefense preparedness. #Biodefense #VaccineInnovation
2026-05-21T00:33:51.995Z